Back to Search
Start Over
948TiP Efficacy and safety of almonertinib in the adjuvant treatment of resectable stage I non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR)-sensitizing mutations in solid and/or micropapillary components.
- Source :
-
Annals of Oncology . 2022 Supplement 7, Vol. 33, pS981-S981. 1p. - Publication Year :
- 2022
- Subjects :
- *EPIDERMAL growth factor receptors
*NON-small-cell lung carcinoma
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159077862
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.1073